Connect with us

Featured Stocks

Surna Inc (OTCMKTS: SRNA) Forecast – Probably the Last Call to Invest



Surna Inc

Surna Inc (OTCMKTS: SRNA) is a manufacturer of environmental control and air sanitation systems for indoor cannabis cultivation facilities. The Boulder-based stock operates both in the US and Canada, providing water and energy-efficient solutions.

Thanks to Surna’s help, cannabis growers can meet the demands which successful cannabis cultivation requires. The company has a lot of experience although there have been failures along the way; even those have collectively have helped it to grow into its successful version.

Surna Stock Price Analysis

Surna’s price had a humble start, which is usually the case with greatest success stories. The company experienced massive growth in 2017 after having experienced some period of stability.

The growth extended to early last year, where the stock price was at $0.100. During that time the price grew almost four times to reach around $0.450. Things, however, got rough the entire last year with constant drops (still no sharp drops).

SRNA price today.

Earlier this year, the drop came to an end, and Surna saw some small surges; however, the damage was already done, the average was already dragged to $0.075. Until March, there was relative stability although there was a decline back to $0.06.

After that, the company’s stock increased again before getting on a continuous drop to where it is currently placed, at $0.0479.

An Overview of Surna Inc

With an array of experience in the industry, Surna has sharpened its expertise offering best solutions alongside teaching clients on ideal conditions for success as well as high-quality marijuana growth.

The company works with a variety of clients, be it an expert or a beginner in the field. The stock has had some ups and downs along the way just like most of the stocks in the industry, but it has gone past them successfully to the point that it’s now placed to take a hike.

Subsequently, Surna Inc. is engaged in the distribution of energy recovery units, chillers, and fan coils. It may seem that there’re no clear-cut updates to trigger a bounce, but technically the stock is on the right track for the big year 2019.

What Surna Inc Has Been Up To

The company had made changes to its management as the year started which clearly had an impact on the stock, seemingly indicating confidence in the stock which is crucial for the price surge. Besides, the new management is proving to propel the company forward in a manner that is required.

Also, not too long ago, Surna signed two project contracts for a combined value of around $4.7 million. The first contract is the new facility construction project for about $2.2 million for a 90,000 sq. Foot indoor marijuana facility built in the Midwest.

The second contract is a facility expansion project for $2.5 million for the 40,000 sq. Foot expansion of the fully operational as well as licensed indoor marijuana cultivation facility.

Another major update was the conversion of $2.76 million of the company’s 10% convertible promissory notes.

The Q4 2018 Report

Recently, Surna issued its Q4 2018 results, and one thing was impressive from the report which points to a bright future for the company. From the report, the revenue for 2018 went up by more than $2 million, compared to that of 2017.

The results meant the stock recorded a significant 33% growth despite the unfriendliness it experienced on the market. Besides, the net loss for 2018 was relatively smaller than that of Q4 2017, meaning the stock is just getting stronger each year.

What Now for Surna?

The company has already set a precise business and strategic plan for this year and 2020, which includes inter-related initiatives too. The plans include such as leveraging the stock brand name, positioning as well as messaging the stock in environmental controls management, and also offering a broader product alongside the service array.

For any indoor grow operation, the firm to look has to be Surna, and given the clear projections the company is working on, the stock is undoubtedly bound to get into an upward movement soon.

For the latest updates on SRNA and the hottest MJ stocks, sign up below!

Disclosure: We have no position in SRNA and have not been compensated for this article.

Photo by Skitterphoto from Pexels

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Featured Stocks

Why Lexaria Bioscience Corp (OTCMKTS:LXRP) Is A Comeback Play



Lexaria Bioscience

Lexaria Bioscience Corp (OTCMKTS:LXRP) brightest days lie ahead. The sentiments shared by Chief Executive Officer, Chris Bunka, are slowly coming to fruition, going by recent price action activity. After a steep pullback in 2019, the stock has once again started climbing higher, as investors react to milestones achieved in 2019 that affirm long-term prospects.

Lexaria Bioscience Catalysts and Price Analysis

A confirmation that the global innovator in drug delivery systems achieved almost everything it set out to accomplish in 2019 continues to strengthen market sentiments. The inking of strategic partnerships with Fortune 500 style companies is another development that the management continues to tout.

Likewise, Lexaria Bioscience succeeded in getting its DehydraTECH technology to market, consequently creating an avenue for generating long-term value. The company’s Intellectual Property strategy has also started to pay dividends, affirming what is at stake going forward. Reports that the company is already experiencing an increase in revenues is another catalyst that continues to shore the stock’s sentiments and prospects in the markets.

Lexaria Bioscience has already started bottoming out from all-time lows in what appears to be the development of a positive trend. A 10% plus rally from one-year lows continue to fuel optimism that the stock has clocked a bottom and due for a correction higher.

Standing in the way of the emerging uptrend is the $0.50 mark, which is the immediate short-term resistance level. A rally followed by a close above the…

Continue Reading

Featured Stocks

Helix TCS Stock (OTCMKTS:HLIX): A Fundamentally Attractive Investment



Helix TCS stock

Helix TCS Stock (OTCMKTS:HLIX) is turning out to be an interesting pick after a steep pullback in 2019. The stock appears to be trading at a big discount going by the solid fundamentals that support a bounce back from current lows. If you are looking for a company seeing plenty of opportunities on the horizon then Helix TCS stock fits the bill.

Helix TCS Stock Catalysts and Price Analysis

The company is currently ranked at number 32 on the Deloitte Technology 500 fastest growing companies. The impressive rating stems from the company reporting impressive financial results depicted by an 80% increase in revenue and a 39% increase in cash flow from operations.

Likewise, the company has moved to strengthen its prospects in the hemp business by launching the nation’s first hemp tracking system. Similarly, the company has inked a strategic partnership with Alt Thirty Six for the launch of digital payments targeting thousands of dispensaries across the U.S

Reports that Helix TCS BioTrack traceability stem processed over $11 million transactions in the first week of recreational sales attest to what could turn out to be a break out year for the company and its technology.

It thus does not come as a surprise that the company’s stock has started to pick up some steam after a roller coaster 2019. A 10% plus rally since the start of the year affirms renewed investor interest in response to the wave of…

Continue Reading

Featured Stocks

Why OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Is A Promising Stock In 2020



OWC Pharmaceutical Research

In 2020, investors are looking for cannabis stocks that can deliver excellent returns following a disappointing 2019, which saw many pot stocks crash to multiyear lows. OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) stands out as a promising cannabis stock to own in 2020.

About OWC Pharmaceutical Research

The cannabis stock universe is vast, so for investors who may have just come across OWC Pharmaceutical for the first time an introduction of the company is in order.

OWC Pharmaceutical is an Israel-based cannabis research company. It is focused on research and development of cannabis-based medical products. The company’s work currently includes development of cannabis-based treatments for a variety of diseases and disorders such as multiple myeloma, psoriasis and fibromyalgia.

Moreover, OWC Pharmaceutical provides consulting services to both government and private entities in the field of medical cannabis programs.

OWC Pharmaceutical Research exited 2019 on a high note

While 2019 ended up being one of the toughest year for cannabis stocks, OWC Pharmaceutical had strong finish to the year. The stock gained 35% on December 31. Before that, the stock rose 65% on December 30. The back-to-back gains in the final days of 2019 helped OWC Pharmaceutical cut its losses for the year but also signaled improving investor sentiment on the stock heading into the new year.

OWC Pharmaceutical finished 2019 at $0.089, having pulled from a low of $0.0045 at the beginning of December.


Continue Reading

MJ Stocks